The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.

Bluejay Capital recapitalized QLS, a cold chain transportation company. QLS focuses on dual temperature trailers to safely transport high-value pharmaceutical cargo. The partnership aims to expand ...

In regulated industries like life sciences, quality and manufacturing have traditionally been built for assurance, not agility. The mission was clear: Ensure compliance, maintain control and reduce ...

Camarillo, California is rapidly emerging as a premier destination for life science companies seeking a strategic location that fosters innovation and growth. Situated in Ventura County, just an hour ...

Blackstone portfolio company BioMed Realty acquires 15-acre Cambridge International Technology Park and 27-acre plot at Granta Park in Cambridge Estimated £850 million investment expected to deliver ...

With around 10,000 diseases known to humankind and over 90% that still have no approved treatments, there’s considerable demand in the specialized life science sector. As Joel Marcus, co-founder and ...

The $700 million Taystee Lab Building sits in the Manhattanville Factory District, but the laboratory goes beyond West Harlem’s manufacturing history. Surrounded by brick buildings on West 126th ...

When a medical device company experiences remarkable revenue growth and expands nationally in just two years, it’s more than a business success story—it represents life-changing innovation that ...

Bluejay Capital Partners, LLC (Bluejay Capital), a specialist in partnering and investing in transportation and logistics businesses, has recapitalized Quality Life Science Logistics & Transportation ...